The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aadi Bioscience Inc | COM | 00032Q104 | 36,935 | 1,529,402 | SH | SOLE | 1,529,402 | 0 | 0 | ||
| Aclaris Therapeutics Inc | COM | 00461U105 | 66,360 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | ||
| Affimed NV | COM | N01045108 | 7,886 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | ||
| Akoya Biosciences Inc | COM | 00974H104 | 6,124 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Astria Therapeutics Inc | COM | 04635X102 | 2,905 | 538,999 | SH | SOLE | 538,999 | 0 | 0 | ||
| Athira Pharma Inc | COM | 04746L104 | 13,030 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| aTyr Pharma Inc | COM | 002120202 | 11,691 | 1,565,000 | SH | SOLE | 1,565,000 | 0 | 0 | ||
| CVRx Inc | COM | 126638105 | 6,523 | 533,370 | SH | SOLE | 533,370 | 0 | 0 | ||
| Celldex Therapeutics Inc | COM | 15117B202 | 33,428 | 865,116 | SH | SOLE | 865,116 | 0 | 0 | ||
| Centessa Pharmaceuticals PLC | SPONS ADR | 152309100 | 12,693 | 1,127,272 | SH | SOLE | 1,127,272 | 0 | 0 | ||
| Chinook Therapeutics Inc | COM | 16961L106 | 20,939 | 1,283,821 | SH | SOLE | 1,283,821 | 0 | 0 | ||
| Cogent Biosciences Inc | COM | 19240Q201 | 9,342 | 1,088,817 | SH | SOLE | 1,088,817 | 0 | 0 | ||
| Corvus Pharmaceuticals Inc | COM | 221015100 | 603 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| GH Research PLC | ORD SH | G3855L106 | 47,173 | 2,021,985 | SH | SOLE | 2,021,985 | 0 | 0 | ||
| Graphite Bio Inc | COM | 38870X104 | 20,045 | 1,612,617 | SH | SOLE | 1,612,617 | 0 | 0 | ||
| Instil Bio Inc | COM | 45783C101 | 117,461 | 6,865,076 | SH | SOLE | 6,865,076 | 0 | 0 | ||
| Kinnate Biopharma Inc | COM | 49705R105 | 13,698 | 773,014 | SH | SOLE | 773,014 | 0 | 0 | ||
| LianBio | SPONS ADR | 53000N108 | 33,131 | 5,378,341 | SH | SOLE | 5,378,341 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q200 | 34,216 | 2,880,096 | SH | SOLE | 2,880,096 | 0 | 0 | ||
| Nuvalent Inc | COM | 670703107 | 15,307 | 803,951 | SH | SOLE | 803,951 | 0 | 0 | ||
| Olema Pharmaceuticals Inc | COM | 68062P106 | 7,644 | 816,651 | SH | SOLE | 816,651 | 0 | 0 | ||
| Relmada Therapeutics Inc | COM | 75955J402 | 51,145 | 2,270,072 | SH | SOLE | 2,270,072 | 0 | 0 | ||
| Travere Therapeutics Inc | COM | 89422G107 | 61,925 | 1,994,997 | SH | SOLE | 1,994,997 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 33,411 | 3,494,851 | SH | SOLE | 3,494,851 | 0 | 0 | ||
| Viridian Therapeutics Inc | COM | 92790C104 | 36,632 | 1,852,919 | SH | SOLE | 1,852,919 | 0 | 0 | ||
| VistaGen Therapeutics Inc | COM | 92840H202 | 31,292 | 16,047,286 | SH | SOLE | 16,047,286 | 0 | 0 | ||